Purchase Order 36C26326P0400
- Not listed
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and self-certified small disadvantaged business, received a $34,000 firm fixed-price purchase order from the Department of Veterans Affairs' Veterans Integrated Service Network 23 (Minneapolis, MN) for transcatheter aortic valve replacement (TAVR) systems. The award, issued on February 6, 2026, with a completion date of February 9, 2026, reflects no set-aside designation and represents a typical procurement structure...
- Edwards Lifesciences LLC, a leading cardiovascular medical device manufacturer and self-certified small disadvantaged business, has been awarded a $34,000 firm fixed-price purchase order by Veterans Integrated Service Network 23 (Minneapolis, Minnesota) for transcatheter aortic valve replacement (TAVR) systems and related cardiac technologies. The award, issued on March 27, 2026, with an ultimate completion date of April 26, 2026, represents a non-set-aside procurement reflecting Edwards...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and self-certified small disadvantaged business, received a $34,000 firm fixed-price purchase order from Veterans Integrated Service Network 23 (Minneapolis, MN) for transcatheter aortic valve replacement (TAVR) systems. The award, issued on March 20, 2026, with an ultimate completion date of March 23, 2026, reflects the VA's critical need for specialized cardiovascular medical devices to support cardiac surgical programs...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and a self-certified small disadvantaged business, was awarded a firm fixed-price purchase order valued at $34,000 by the U.S. Department of Veterans Affairs through Veterans Integrated Service Network 23 on September 23, 2025. The contract, which is not set-aside designated, covers transcatheter aortic valve replacement (TAVR) medical devices and is scheduled for completion by September 24, 2025. The award supports the...
- The Department of Veterans Affairs, Veterans Integrated Service Network 23 (Minneapolis) awarded a $34,000 firm fixed-price purchase order to Edwards Lifesciences LLC for transcatheter aortic valve replacement (TAVR) systems on April 3, 2026, with an ultimate completion date of April 6, 2026. This contract was awarded without a set-aside designation and represents a direct procurement of specialized cardiovascular medical devices essential to the VA's cardiac surgical programs. Edwards...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and a self-certified small disadvantaged business, received a $34,000 firm fixed-price purchase order from Veterans Integrated Service Network 23 (Minneapolis) on January 30, 2026, for transcatheter aortic valve replacement (TAVR) systems. The contract, with an ultimate completion date of March 1, 2026, carries no set-aside designation and represents a sole-source procurement reflecting the contractor's exclusive...
- Edwards Lifesciences LLC received a $34,000 firm fixed-price purchase order from Veterans Integrated Service Network 23 (Minneapolis VA) for transcatheter aortic valve replacement (TAVR) systems, with an ultimate completion date of January 20, 2026. This contract, awarded on January 16, 2026, carries no set-aside designation and represents Edwards Lifesciences' specialized supply of advanced cardiovascular medical devices to the Department of Veterans Affairs. The award is structured as a...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation specializing in advanced cardiovascular medical devices, was awarded a $34,000 firm fixed-price purchase order by Veterans Integrated Service Network 23 (Minneapolis, MN) on March 13, 2026, with an ultimate completion date of March 16, 2026. The contract, which carries no set-aside designation, is for transcatheter aortic valve replacement (TAVR) systems and related cardiac technologies to support the Department of...
- The Department of Veterans Affairs, Veterans Integrated Service Network 23 (Minneapolis, MN), awarded a $34,000 firm fixed-price purchase order to Edwards Lifesciences LLC for transcatheter aortic valve replacement (TAVR) systems on February 9, 2026, with completion scheduled for February 10, 2026. This contract, issued with no set-aside designation, represents a sole-source procurement reflecting Edwards Lifesciences LLC's exclusive manufacturing capability for these specialized...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and self-certified small disadvantaged business, has been awarded a firm fixed-price purchase order valued at $34,000 by Veterans Integrated Service Network (VISN) 23 for transcatheter aortic valve replacement (TAVR) medical devices. The contract was awarded on November 10, 2025, with an ultimate completion date of November 12, 2025, and will be performed in Minneapolis, Minnesota. This award represents a direct...
Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and self-certified small disadvantaged business, received a $34,000 firm fixed-price purchase order from Veterans Integrated Service Network 23 (Minneapolis) for transcatheter aortic valve replacement (TAVR) systems. The award, announced on April 17, 2026, with an ultimate completion date of April 20, 2026, represents a sole-source procurement reflecting Edwards Lifesciences' exclusive manufacturing capability for these specialized cardiovascular devices. This purchase order carries no set-aside designation and will be performed in Minneapolis, Minnesota. This contract award is part of Edwards Lifesciences LLC's extensive portfolio of cardiovascular device procurement with the Department of Veterans Affairs, through which the company has received over 200 prime federal contract awards since 2025. The company maintains two primary indefinite delivery contracts with the VA totaling $7.45M in ceiling value: a $6.5M five-year consignment services agreement with VISN 21 (effective January 1, 2026–December 31, 2030) and a $950,000 five-year supply contract with VISN 15 (effective October 20, 2025–October 19, 2030). Edwards Lifesciences serves as the VA's primary framework supplier of advanced cardiac surgical implants, transcatheter heart valves including SAPIEN 3 and SAPIEN 3 Ultra models, and related cardiovascular technologies essential to supporting veteran patient outcomes across multiple service networks.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
6515--PROS V23 618 UNU BILL & REPLACE 6183024098 (MI) TAVR (NEED ON OR BEFORE 04/21/2026) (VA-26-00062434) | 36C26326Q0587 | Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 23 | Award Notice 1/1 | 4/17/26, 1:51 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $34.0k | 4/16/26 |